EDEN Bioscience Effects 1-for-3 Reverse Stock Split
Published: Feb 25, 2008
BOTHELL, WA--(Marketwire - February 22, 2008) - Eden Bioscience Corporation (NASDAQ: EDEN) today announced that on February 21, 2008, the Company filed an amendment to its Restated Articles of Incorporation that effects a 1-for-3 reverse stock split of the Company's outstanding common stock. The reverse stock split will be effective with respect to shareholders of record at 5:00 p.m., Pacific standard time, on February 22, 2008. As a result of the reverse stock split, each three shares of common stock will be combined and reclassified into one share of common stock and the total number of shares outstanding will be reduced from approximately 8.1 million shares to approximately 2.7 million shares.